Inhibition of YTHDF1 by salvianolic acid overcomes gluten-induced intestinal inflammation

Affiliations

• ¹ Department of Biochemistry and Molecular Biology, University of the Basque Country, UPV/EHU, Leioa, Spain.
• ² Biobizkaia Health Research Institute, Barakaldo, Spain.
• ³ Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, UPV/EHU, Leioa, Spain.
• ⁴ Department of Biochemistry and Physiology, School of Pharmacy and Food Sciences, Universitat de Barcelona, Barcelona, Spain.
• ⁵ Institut de Biomedicina de la Universitat de Barcelona (IBUB), Universitat de Barcelona, Barcelona, Spain.
• ⁶ Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
• ⁷ Research Centre for Experimental Marine Biology and Biotechnology (PiE-UPV/EHU), University of the Basque Country, UPV/EHU, Plentzia, Spain.
• ⁸ BCTA Research Group, Department of Zoology and Animal Cell Biology, University of the Basque Country, UPV-EHU, Leioa, Spain.
• ⁹ Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute, Donostia University Hospital, Donostia-san Sebastian, Spain.
• ¹⁰ State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Science, Beijing, Beijing, China.
• ¹¹ Department of Medicine, Faculty of Medicine and Nursing, University of the Basque Country, UPV/EHU, Leioa, Spain.
• ¹² Centro de Investigación Biomédica en Red enfermedades hepaticas y digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
• ¹³ Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan, China.
• ¹⁴ Department of Chemistry, Department of Biochemistry and Molecular Biology, University of Chicago, Chicago, Illinois, USA.
• ¹⁵ Howard Hughes Medical Institute, Chicago, Illinois, USA.
• ¹⁶ Biobizkaia Health Research Institute, Barakaldo, Spain ainara.castellanos@ehu.eus.
• ¹⁷ Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, Madrid, Spain.
• ¹⁸ IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.